CBT

Value 202020212022202320242025 TTM Total revenue 2.61 B3.41 B4.32 B3.93 B3.99 B3.71 B 3.58 B Gross profit 500 M799 M885 M839 M960 M940 M 885 M Operating expenses 369 M356 M290 M314 M360 M331 M 354 M Selling/general/admin expenses 292 M289 M258 M253 M283 M260 M 266 M Research & development 57 M56 M55 M57 M63 M59 M 57 M Operating income 21 M454 M389 M526 M614 M621 M 562 M Non-Operating Income, Total -1 M1 M26 M24 M-4 M20 M 21 M Interest expense, net of interest capitalized 53 M49 M56 M90 M81 M76 M 75 M Non-Operating Income, excl. Interest Expenses -45 M-41 M-21 M-50 M-49 M-49 M -47 M Unusual income/expense -9 M-7 M-9 M-16 M-36 M-7 M -7 M Pretax income -30 M409 M345 M456 M535 M572 M 514 M Equity in earnings 3 M3 M10 M5 M6 M7 M 6 M Taxes 191 M123 M102 M-28 M111 M196 M 187 M Non-controlling/minority interest 17 M36 M34 M39 M44 M45 M 42 M After tax other income/expense -8 M-21 M-20 M-4 M-63 M-24 M -23 M Net income before discontinued operations -238 M250 M209 M445 M380 M331 M 285 M Discontinued operations —————— — Net income -238 M250 M209 M445 M380 M331 M 285 M Dilution adjustment —-2 M-2 M——— — Preferred dividends —1 M1 M——— — Diluted net income available to common stockholders -238 M247 M206 M437 M374 M326 M 281 M Basic earnings per share (Basic EPS) -4.214.353.657.796.796.07 5.32 Diluted earnings per share (Diluted EPS) -4.214.343.627.736.726.02 5.3 Average basic shares outstanding 56.6 M56.7 M56.5 M56.1 M55.1 M53.7 M — Diluted shares outstanding 56.6 M56.8 M56.9 M56.5 M55.7 M54.2 M — EBITDA 289 M603 M741 M669 M751 M763 M 700 M EBIT 131 M443 M595 M525 M600 M609 M 531 M Cost of revenue 2.11 B2.61 B3.44 B3.09 B3.03 B2.77 B 2.69 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 158 M160 M146 M144 M151 M154 M 169 M